July
Children:
Alzheimer’s Disease Risk Impacted by the Liver, Diet
Aspirin Desensitization Improves Alcohol-Induced Allergies in Patients with Underlying Respiratory Disease
Therapy for Rare Cancers Receives FDA Approval Following Trials at Penn’s Abramson Cancer
Brain Stimulation Decreases Intent to Commit Physical, Sexual Assault
Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 Therapy
Chance of Being Prescribed Opioids for a Minor Injury Differs Dramatically by Where You Live
Diabetes Drugs Act as Powerful Curb for Immune Cells in Controlling Disease-causing Inflammation
Fat Production and Burning Are Synchronized in Livers of Mice with Obesity, Penn Study Finds
Federal Government Approves Penn Medicine to Develop Imaging Guidelines
Genome Editing Reduces Cholesterol in Large Animal Model, Laying the Groundwork for In-Human Trials
Greening Vacant Lots Reduces Feelings of Depression in City Dwellers, Penn Study Finds
Immunologist Named Chair of Systems Pharmacology
Largest Genetic Database on Alzheimer’s Disease Now Re-open for Business
News Release
Nudging Doctors to Prescribe Cholesterol Lowering Statins Triples Prescription Rates
Penn led Study Finds Mutation Driving Deadlier Brain Tumors and Potential Therapy to Stop It
Penn Medicine Emergency Medicine Physician and Digital Health Care Innovator Raina Merchant, MD, Named Aspen Institute Health Innovator Fellow
Penn Medicine Named Among Nation’s Best Employers for Women by Forbes
Penn Medicine Pulmonologist and Medical Educator Jessica Dine MD Named Macy Faculty Scholar
Penn Medicine’s Garret FitzGerald, Cardiovascular Disease and Translational Medicine Expert, Elected to Italian Science Academy
Penn Medicine’s John Q. Trojanowski Receives Lifetime Achievement Award from Alzheimer’s Association
Penn Wissahickon Hospice and Caring Way Earn the Circle of Life Award® from American Hospital Association for Innovative Palliative and End-of-Life Care
Penn’s Brian Capell, MD, PhD, Wins Damon Runyon Clinical Investigator Award
Red-Blood-Cell “Hitchhikers” Offer New Way to Transport Drugs to Specific Targets
Rethinking Neurodegenerative Disease Treatment: Target Multiple Pathological Proteins, Not Just One
Why Randomized Trials for Proton Therapy Are Difficult to Complete (And What We Can Do About It)